Ali Ziad A, Karimi Galougahi Keyvan, Nazif Tamim, Maehara Akiko, Hardy Mark A, Cohen David J, Ratner Lloyd E, Collins Michael B, Moses Jeffrey W, Kirtane Ajay J, Stone Gregg W, Karmpaliotis Dimitri, Leon Martin B
Division of Cardiology, Center for Interventional Vascular Therapy, New York Presbyterian Hospital and Columbia University, New York, NY, USA
Cardiovascular Research Foundation, New York, NY, USA.
Eur Heart J. 2016 Oct 21;37(40):3090-3095. doi: 10.1093/eurheartj/ehw078. Epub 2016 Mar 7.
The feasibility, safety, and clinical utility of percutaneous coronary intervention (PCI) without radio-contrast medium in patients with advanced chronic kidney disease (CKD) are unknown. In this series, we investigated a specific strategy for 'zero contrast' PCI with the aims of preserving renal function and preventing the need for renal replacement therapy (RRT) in patients with advanced CKD.
A total of 31 patients with advanced CKD [creatinine = 4.2 mg/dL, inter-quartile range (IQR) 3.1-4.8, estimated glomerular filtration rate = 16 ± 8 mL/min/1.73 m] who had clinical indication for PCI based on a prior minimal contrast coronary angiogram were included. Zero contrast PCI was performed at least 1 week after diagnostic angiography using real-time intravascular ultrasound (IVUS) guidance, with pre- and post-PCI measurements of fractional flow reserve and coronary flow reserve to confirm physiological improvement. This approach resulted in successful PCI, no major adverse cardiovascular events and preservation of renal function without the need for RRT within a follow-up time of 79 days (IQR 33-207) in all patients.
In patients with advanced CKD who require revascularization, PCI may safely be performed without contrast using IVUS and physiological guidance with high procedural success and without complications.
对于晚期慢性肾脏病(CKD)患者,不使用放射性造影剂进行经皮冠状动脉介入治疗(PCI)的可行性、安全性及临床实用性尚不清楚。在本系列研究中,我们探讨了一种“零造影剂”PCI的特定策略,旨在保护晚期CKD患者的肾功能并避免其需要肾脏替代治疗(RRT)。
共有31例晚期CKD患者[肌酐=4.2mg/dL,四分位数间距(IQR)3.1 - 4.8,估计肾小球滤过率=16±8mL/min/1.73m²]纳入研究,这些患者基于之前的最小造影剂冠状动脉造影有PCI的临床指征。在诊断性血管造影至少1周后,使用实时血管内超声(IVUS)引导进行零造影剂PCI,并在PCI前后测量血流储备分数和冠状动脉血流储备以确认生理改善情况。该方法在所有患者79天(IQR 33 - 207)的随访期内均成功完成PCI,无重大不良心血管事件,且肾功能得以保留,无需RRT。
对于需要血运重建的晚期CKD患者,使用IVUS和生理指标引导,不使用造影剂进行PCI可能安全可行,手术成功率高且无并发症。